APPLICATION
ANDA206868
TYPE
ANDA
ORIGINAL APPROVAL
2022-01-24
LATEST ACTION
2025-01-31
ROUTE
ORAL
DOSAGE FORM
TABLET, CHEWABLE
MARKETING STATUS
Prescription
Products
LANTHANUM CARBONATEPrescription
LANTHANUM CARBONATE EQ 750MG BASE · TABLET, CHEWABLE · ORAL
LANTHANUM CARBONATEPrescription
LANTHANUM CARBONATE EQ 1GM BASE · TABLET, CHEWABLE · ORAL
LANTHANUM CARBONATEPrescription
LANTHANUM CARBONATE EQ 500MG BASE · TABLET, CHEWABLE · ORAL
Approval history
2025-01-31Labeling · Supplement 5 · standardAP
2023-12-06Labeling · Supplement 4 · standardAP
2022-01-24UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.